[Intestinal candidiasis: modern therapeutic tactics].
Bowels candidiasis is an urgent problem not only for gastroenterology but also for other fields of medicine--gynecology, dentistry, phthisiology, surgery, etc. as this disease is directly related with the manifestations of systemic candidiasis in other organs. The diagnostics algorithm includes the detection of a filamentary form (pseudomyceliums) of micromycetes of the Candida genus in the morphological study of a tissue sampling of the bowels mucous coat. The drug of choice for the treatment of bowels candidiasis is Pimafucin (Natamycin) having a local action on the Candida fungi in the intestinal lumen in the absence of any systemic absorption of the drug or any side effects.
Zlatkina
A R
AR
D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D003692:Delayed-Action Preparations; D004760:Enterocolitis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D006801:Humans; D010866:Natamycin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009761:Nystatin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000935:Antifungal Agents; D003692:Delayed-Action Preparations; D009761:Nystatin; D010866:Natamycin